Altshuler Shaham LTD Red Hill Biopharma Ltd. Transaction History

Altshuler Shaham LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$0.14 - $5.6 $3,710 - $148,400	-26,500 Closed	0 $0
Q4 2022 May 09, 2023	BUY	$0.14 - $695.9 $3,710 - $18.4 Million	26,500 New	26,500 $3,000
Q4 2018 Feb 11, 2019	SELL	$5.18 - $9.35 $1,792 - $3,235	-346 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$6.0 - $11.35 $153,270 - $289,935	-25,545 Reduced 98.66%	346 $1,000
Q2 2018 Aug 13, 2018	SELL	$4.82 - $8.53 $562,050 - $994,666	-116,608 Reduced 81.83%	25,891 $61,000
Q1 2018 May 15, 2018	SELL	$4.96 - $6.84 $133,657 - $184,317	-26,947 Reduced 15.9%	142,499 $209,000
Q4 2017 May 14, 2018	BUY	$4.58 - $10.81 $776,062 - $1.83 Million	169,446	169,446 $251,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.